FDA approves new spina bifida treatment that utilizes scopes

A new treatment that allows surgeons to treat spina bifida prior to birth using scopes has been approved by the FDA, reports The Post Bulletin.

Advertisement

It has been labeled as fetoscopic surgery for the treatment of spina bifida and improves outcomes for both baby and mother using minimally invasive techniques.

This treatment usually allows the mother to deliver vaginally with her home care team and improves the likelihood of delivering the baby at term.

Prenatal spina bifida surgery increases the chance that the baby will walk while lowering the risk of hydrocephalus-related outcomes and the development of Chiari malformation.

Standard spina bifida treatment involves surgery after birth. By going through the uterus, surgeons can fix the condition during the second trimester; however procedure risks include uterine rupture, cesarean birth and premature labor.

More articles on devices:
Innovasis HA PEEK Data Registry enrolls 150 patients
Anika to present regenerative medicine and orthobiologics developments
Joimax presents new spine device at Global Spine Congress

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.